Patients typically see measurable fat loss within 4-6 weeks, though initial weight changes include water loss and reduced food volume in the digestive tract
Enforcement steps According to the advisory, Health Canada is actively monitoring the marketplace and is continuing to take action against the sale and advertisement of these products in stores and online, including seizures and the issuance of compliance or warning letters
Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Pilitsi E, et al
Telehealth weight management visits have expanded significantly since the pandemic-era regulatory changes, and many payers continue to cover telehealth prescribing visits for GLP-1 medications
Ozempic is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus treatment